幽门狭窄合并克罗恩病对阿达木单抗治疗有反应。
Pyloric stenosis associated Crohn's disease responding to adalimumab therapy.
作者信息
Gaggar Sameer, Scott John, Thompson Nicholas
机构信息
Sameer Gaggar, Nicholas Thompson, Department of Gastroenterology, Freeman Hospital, NE7 7DN Newcastle, United Kingdom.
出版信息
World J Gastrointest Pharmacol Ther. 2012 Dec 6;3(6):97-9. doi: 10.4292/wjgpt.v3.i6.97.
Abstract
Gastroduodenal Crohn's disease (CD) is rare and the response to standard medical therapy is often poor. Anti-tumor necrosis factor therapy has revolutionised the treatment of CD. We present a patient with pyloric stenosis associated with CD which improved with Adalimumab therapy. We recommend considering anti-tumor necrosis factor therapy in symptomatic gastroduodenal CD.
摘要
胃十二指肠克罗恩病（CD）较为罕见，对标准药物治疗的反应通常较差。抗肿瘤坏死因子疗法彻底改变了CD的治疗方式。我们报告了1例与CD相关的幽门狭窄患者，其经阿达木单抗治疗后病情改善。我们建议对有症状的胃十二指肠CD考虑采用抗肿瘤坏死因子疗法。
相似文献
1
Pyloric stenosis associated Crohn's disease responding to adalimumab therapy.
World J Gastrointest Pharmacol Ther. 2012 Dec 6;3(6):97-9. doi: 10.4292/wjgpt.v3.i6.97.
2
Pyloric stenosis as a manifestation of isolated gastric Crohn's disease responding to intralesional steroid injection and balloon dilation: a case report.
J Med Case Rep. 2019 Nov 13;13(1):331. doi: 10.1186/s13256-019-2272-8.
3
Pyloric Stenosis: A Rare Manifestation of Crohn's Disease.
J Community Hosp Intern Med Perspect. 2022 Jan 31;12(1):39-42. doi: 10.55729/2000-9666.1007. eCollection 2022.
4
[Pyloric stenosis as a presenting clinical pattern of Crohn's disease].
Rev Med Inst Mex Seguro Soc. 2010 Sep-Oct;48(5):553-6.
5
A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-α) inhibitors, adalimumab and infliximab, for Crohn's disease.
Health Technol Assess. 2011 Feb;15(6):1-244. doi: 10.3310/hta15060.
6
Actual Anti-TNF Trough Levels Relate to Serum IL-10 in Drug-Responding Patients With Crohn's Disease.
Inflamm Bowel Dis. 2019 Jul 17;25(8):1357-1366. doi: 10.1093/ibd/izz012.
7
Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease.
Cochrane Database Syst Rev. 2008 Jan 23(1):CD006893. doi: 10.1002/14651858.CD006893.
8
Pyloric stenosis due to Crohn's disease.
J Gastroenterol. 1998 Oct;33(5):739-42. doi: 10.1007/s005350050165.
9
Early treatment with anti-tumor necrosis factor agents improves long-term effectiveness in symptomatic stricturing Crohn's disease.
United European Gastroenterol J. 2020 Nov;8(9):1056-1066. doi: 10.1177/2050640620947579. Epub 2020 Jul 28.
10
Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
BioDrugs. 2010 Dec 14;24 Suppl 1:3-14. doi: 10.2165/11586290-000000000-00000.
引用本文的文献
1
Case report and review of literature: IgG4-gastroduodenitis in upper GI Crohn's disease: two separate entities or just a marker of disease severity?
Front Med (Lausanne). 2024 Jul 19;11:1388940. doi: 10.3389/fmed.2024.1388940. eCollection 2024.
2
Duodenal Crohn's disease: Case report and systematic review.
World J Methodol. 2024 Mar 20;14(1):88619. doi: 10.5662/wjm.v14.i1.88619.
3
Gastric and Duodenal Fistulas in Crohn's Disease, a Surgical Challenge: Report of 5 Cases and a Review of the Literature.
Am J Case Rep. 2023 Sep 4;24:e940644. doi: 10.12659/AJCR.940644.
4
An Obscure Presence of Gastroduodenal Involvement in a Newly Diagnosed Ileocolonic Crohn's Disease Patient.
Case Rep Gastrointest Med. 2022 Dec 27;2022:2200438. doi: 10.1155/2022/2200438. eCollection 2022.
5
Pyloric Stenosis: A Rare Manifestation of Crohn's Disease.
J Community Hosp Intern Med Perspect. 2022 Jan 31;12(1):39-42. doi: 10.55729/2000-9666.1007. eCollection 2022.
6
Pediatric Crohn's disease with severe morbidity manifested by gastric outlet obstruction: two cases report and review of the literature.
Intest Res. 2021 Oct;19(4):472-477. doi: 10.5217/ir.2020.00072. Epub 2020 Oct 29.
7
Pyloric stenosis as a manifestation of isolated gastric Crohn's disease responding to intralesional steroid injection and balloon dilation: a case report.
J Med Case Rep. 2019 Nov 13;13(1):331. doi: 10.1186/s13256-019-2272-8.
8
Crohn's disease of esophagus, stomach and duodenum.
World J Gastrointest Pharmacol Ther. 2019 Mar 7;10(2):35-49. doi: 10.4292/wjgpt.v10.i2.35.
本文引用的文献
1
Treatment of isolated gastric Crohn's disease with inhaled corticosteroids.
Case Rep Gastroenterol. 2008 Nov 5;2(3):363-8. doi: 10.1159/000158543.
2
Duodenal Crohn's disease successfully treated with adalimumab.
Endoscopy. 2011;43 Suppl 2 UCTN:E22. doi: 10.1055/s-0030-1255893. Epub 2011 Jan 26.
3
Thyroid function tests: a review.
Eur Rev Med Pharmacol Sci. 2009 Sep-Oct;13(5):341-9.
4
Successful treatment of refractory duodenal Crohn's disease with infliximab.
Dig Dis Sci. 2007 Jan;52(1):31-2. doi: 10.1007/s10620-006-9585-3. Epub 2006 Dec 14.
5
Successful infliximab therapy for a duodenal stricture caused by Crohn's disease.
Inflamm Bowel Dis. 2005 Dec;11(12):1123-5. doi: 10.1097/01.mib.0000191612.43584.94.
6
Role of strictureplasty in surgical treatment of Crohn's disease.
J Gastroenterol. 2005 Mar;40 Suppl 16:35-9. doi: 10.1007/BF02990577.
7
Gastroduodenal Crohn's disease: medical management.
Inflamm Bowel Dis. 2003 Mar;9(2):127-8; discussion 131. doi: 10.1097/00054725-200303000-00008.
8
Upper gastrointestinal tract endoscopy in inflammatory bowel disease.
Gastrointest Endosc Clin N Am. 2002 Jul;12(3):451-62, vii. doi: 10.1016/s1052-5157(02)00006-5.
9
Inflammatory bowel disease. Medical therapy of specific clinical presentations.
Gastroenterol Clin North Am. 2002 Mar;31(1):185-202, x. doi: 10.1016/s0889-8553(01)00012-7.
10
Crohn's disease of the foregut.
Surg Clin North Am. 2001 Feb;81(1):117-35, viii. doi: 10.1016/s0039-6109(05)70276-0.
Zotero 插件